The Effect of OC000459 on Eosinophilic Airway Inflammation and Asthma Control in Subjects With Refractory Eosinophilic Asthma: a Randomised, Double-blind, Placebo Controlled Trial
Phase of Trial: Phase II
Latest Information Update: 27 Mar 2018
At a glance
- Drugs Timapiprant (Primary)
- Indications Asthma
- Focus Proof of concept; Therapeutic Use
- Sponsors Atopix Therapeutics
- 21 Mar 2018 Planned End Date changed from 1 Sep 2017 to 1 Jun 2018.
- 21 Mar 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Jun 2018.
- 03 Oct 2016 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.